+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Cartilage Degeneration Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Procedure Type; Application; and End User and Country - Regional Analysis and Market Forecasts by Procedure Type, Application and End User

  • ID: 5180778
  • Report
  • September 2020
  • Region: Europe
  • 110 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2021

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • CartiHeal, Inc
  • Smith & Nephew
  • Stryker Corporation
  • Vericel Corporation
  • MORE
The Europe cartilage degeneration market is expected to reach US$ 3,365.09 million by 2027 from US$ 2,463.16 million in 2019; it is estimated to grow at a CAGR of 4.1% from 2020 to 2027.

The cartilage degeneration market in Europe is growing primarily due to the increasing prevalence of sports injuries and obesity. However, high cost of cartilage therapies and lack of reimbursement scenario are the factors restraining the growth of the market in this region. Nevertheless, the growing number of product approvals and rising emphasis on regenerative medicines are likely to fuel the growth of the Europe cartilage degeneration market during the forecast period.

Degeneration of cartilage leads to pain and chronic inflammation in joints of a human body. Furthermore, damaged cartilage can potentially influence the quality of a patient’s life. Continuous research and developments are innovating new techniques and methodologies to deal with damaged cartilages. A few of these techniques comprise joint replacement, cell therapies, and chondroplasty.

Companies in the cartilage degeneration market are undertaking various R& D activities to introduce more innovative products. For instance, in September 2013, OligoMedic, Inc., a global designer, manufacturer, and distributor of osteoarthritis products, launched its CE mark injectable implant JointRep™ for the treatment of cartilage articular joint defect. Also, the new cartilage therapies are enabling the adoption of advanced cell technologies, which are, in turn, strengthening the procedural outcomes. Furthermore, in May 2017, Co. DON AG got European Medicines Agency (EMA) approval for its Spherox, a knee cartilage repair product for the treatment of symptomatic articular cartilage defects in femoral condyle and patella

The players operating in the cartilage degeneration market are focusing on establishing collaborations and partnerships for the development of advanced products with increasing procedural efficiency. For instance, in October 2018, Gelmetix, a UK-based player, and Stemmatters, a Portuguese regenerative medicine company, entered into a strategic partnership for the innovation and development of an advanced knee cartilage repair device. hus, the increasing number of product approvals, developments, advanced technologies, and strategic activities are projected to offer lucrative opportunities for the growth of the market.

The European economy is severely affected due to the exponential rise in the number of COVID-19 patients in this region. The Medical Device Regulation (MDR) requires manufacturers to conduct Post Market Clinical Follow-Up (PMCF) studies to demonstrate the continued safety and performance of their devices. This is expected to impact the product launch and ongoing clinical trials of medical devices, thereby hampering the sales and market growth. Also, disrupted supply chains, extended lockdowns, and canceling of other medical procedures have adversely affected the growth of the cartilage degeneration market in Europe.

The knee segment accounted for the largest share of the market in 2019. The growth of this segment is attributed to the increasing prevalence of knee injuries. For instance, according to a study published - based on NCBI data - on an online newspaper, one in four adults suffer from chronic knee pain in this region. Moreover, the prevalence of knee pain has witnessed a massive growth of around 40.0% during the past 4 decades. Furthermore, the increasing awareness of benefits provided by cartilage repair is anticipated to drive the growth of the knee segment.

The major secondary sources associated with the Europe cartilage degeneration market report are the World Health Organization (WHO), British Journal of Sports Medicine, European Society of Sports Traumatology, Knee Surgery, Arthroscopy (ESSKA), Organization for Economic Cooperation and Development (OECD), and others.

Reasons to Buy
  • Understand the Europe cartilage degeneration market landscape and identify segments that are most likely to guarantee a strong return.
  • Stay ahead of the race by comprehending the ever-changing competitive landscape in the region.
  • Efficiently plan mergers and acquisitions, and partnership deals in the Europe cartilage degeneration market by identifying segments with the most promising probable sales.
  • Take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments.
  • Obtain revenue forecast of market based on various segments for the period 2019-2027.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • CartiHeal, Inc
  • Smith & Nephew
  • Stryker Corporation
  • Vericel Corporation
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Europe Cartilage Degeneration Market - By Procedure Type
1.3.2 Europe Cartilage Degeneration Market - By Application
1.3.3 Europe Cartilage Degeneration Market- By End User
1.3.4 Europe Cartilage Degeneration Market - By Country

2. Europe Cartilage Degeneration Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Cartilage Degeneration Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cartilage Degeneration Market - Europe PEST Analysis
4.3 Expert Opinion

5. Europe Cartilage Degeneration Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Number of Sports Injuries
5.1.2 Increasing Prevalence of Obesity
5.2 Key Market Restraints
5.2.1 High Cost of Cartilage Repair Therapies
5.3 Key Market Opportunities
5.3.1 Growing Number of Product Approvals and Developments
5.4 Future Trends
5.4.1 Rising Emphasis on Regenerative Medicines
5.5 Impact analysis

6. Cartilage Degeneration Market - Europe Analysis
6.1 Europe Cartilage Degeneration Market Revenue Forecasts and Analysis

7. Europe Cartilage Degeneration Market Analysis and Forecasts To 2027 - By Procedure Type
7.1 Overview
7.2 Europe Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)
7.2.1 Europe Cartilage Degeneration Market Revenue and Forecasts to 2027, By Procedure Type (US$ Mn)
7.3 Osteochondral Transplant
7.3.1 Overview
7.3.2 Europe Osteochondral Transplant Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Chondroplasty
7.4.1 Overview
7.4.2 Europe Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Joint Replacement
7.5.1 Overview
7.5.2 Europe Joint Replacement Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Meniscus Transplants
7.6.1 Overview
7.6.2 Europe Meniscus Transplants Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Cell-based Cartilage Resurfacing
7.7.1 Overview
7.7.2 Europe Cell-based Cartilage Resurfacing Market Revenue and Forecast to 2027 (US$ Mn)
7.8 Other Procedures
7.8.1 Overview
7.8.2 Europe Other Procedures Market Revenue and Forecast to 2027 (US$ Mn)

8. Europe Cartilage Degeneration Market Analysis and Forecasts To 2027 - By Application
8.1 Overview
8.2 Europe Cartilage Degeneration Market, By Application 2019 & 2027 (%)
8.2.1 Europe Cartilage Degeneration Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Knee
8.3.1 Overview
8.3.2 Europe Knee Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hip
8.4.1 Overview
8.4.2 Europe Hip Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Other Applications
8.5.1 Overview
8.5.2 Europe Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

9. Europe Cartilage Degeneration Market Analysis - By End-User
9.1 Overview
9.2 Europe Cartilage Degeneration Market, By End-User 2019-2027 (%)
9.2.1 Europe Cartilage Degeneration Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Hospitals and Specialty Centres
9.3.1 Overview
9.3.2 Europe Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Ambulatory Surgical Centres
9.4.1 Overview
9.4.2 Europe Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Europe Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

10. Cartilage degeneration Market Revenue and Forecasts To 2027 - Geographical Analysis
10.1 Europe Cartilage degeneration Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Europe: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Europe: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.4 Europe: Cartilage Degeneration Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.5 Europe: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)
10.1.6 Europe: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
10.1.7 Germany: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Germany: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Germany: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Germany: Cartilage Degeneration Market, by Application- Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Germany: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)
10.1.8 France: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 France: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 France: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 France: Cartilage Degeneration Market, by Application- Revenue and Forecast to 2027 (USD Million)
10.1.8.4 France: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)
10.1.9 UK: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 UK: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 UK: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 UK: Cartilage Degeneration Market, Application - Revenue and Forecast to 2027 (USD Million)
10.1.9.4 UK: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)
10.1.10 Italy: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Italy: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Italy: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.10.3 Italy: Cartilage Degeneration Market, by Application- Revenue and Forecast to 2027 (USD Million)
10.1.10.4 Italy: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)
10.1.11 Spain: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Spain: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Spain: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Spain: Cartilage Degeneration Market, by Application- Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Spain: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Europe Cartilage degeneration Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Company Profiles
12.1 B. Braun Melsungen AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Smith & Nephew
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Stryker Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 CartiHeal, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Vericel Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
Note: Product cover images may vary from those shown
  • B. Braun Melsungen AG
  • Smith & Nephew
  • Stryker Corporation
  • CartiHeal, Inc
  • Vericel Corporation
Note: Product cover images may vary from those shown
Adroll
adroll